# Phase 2 Readiness (from Phase 1 baseline `aa6d9e91`)

Directive FG-P1-COMPLETION-REVIEW-20260909-01. Based only on repository evidence and the adopted architecture. **This document authorizes nothing.** Phase 2 implementation requires its own Founder directive.

## Determination

**B. PHASE 1 COMPLETE WITH EXPLICIT CARRY-FORWARD ITEMS.**

Why not A: the verification plan Phase 1 was executed against (VERIFICATION_PLAN section 2-4, section 6; execution plan slice 7) required a runtime case per writer, `inv-run` on a new-activity copy, the six D6 datasets, Q14 parity and a Phase 2a matrix re-run. The delivered evidence (44/44 + 23/23, static 33/33, production `inv-run`/`gm-verify`/`replay-verify`) is internally consistent and shows no regression, but it is narrower than the plan. Phase 1 is not "complete without qualification" until either that evidence exists or the Founder accepts the delivered standard.

Why not C: every Phase 1 unit (1.1-1.5, 1.7, 1.8; 1.6 correctly has no action) is implemented in the committed tree; the boundary is intact; production data, schema and D11 are unchanged; no new failure, drift, duplication or mismatch was found; the one disclosed gap (T-W20) was closed at runtime. Nothing found blocks Phase 2 architecture work or would be invalidated by the carry-forward verification.

## What "Phase 2" means here

Master Plan section 05: Phase 2a (folio authorization) is **COMPLETED** and frozen at `237db2ad`. The next phase is **Phase 2b** (maker-checker). Its entry conditions, verbatim from the plan: *"Phase 1 complete; MP-D9 and MP-D5 settled."* MP-D5 is ADOPTED (Level 2 floor). MP-D9 (operator profile) is **OPEN** with an interim Admin/Manager default applied in Phase 2a. Phase 2b also needs the maker-checker operation-matrix ADR (B-2; ADR-010 stays PROPOSED until it exists).

## Gates that must be satisfied before a Phase 2 implementation directive

| Gate | What satisfies it | Kind | Blocks |
|---|---|---|---|
| **G-1 Phase 1 verification completion** | A bounded, read-only, copies-only verification directive at `aa6d9e91` producing: (a) a runtime case per remaining writer (18) with audit-failure injection at each touched writer, or a Founder ruling that the static 33/33 proof plus six runtime writers is the accepted Phase 1 standard; (b) `inv-run` on a new-activity copy with INV-A02/A03 HOLD and INV-B01-B03 HOLD after a close; (c) `ds-run`/`ds-coverage` six datasets green, Q14 AGREED; (d) Phase 2a 29-case matrix re-run. No code change is expected; any failure found would reopen Phase 1. | Verification | Phase 2 directive |
| **G-2 Phase 1 acceptance recorded** | Founder review outcome appended to `FOUNDER_DECISIONS.md` (and MASTER_PLAN overlay) indexing FG-P1-EXEC-20260909-01, the Golden Master recapture, the W-20 closure, the five-commit release and this review; Phase 1 status set to COMPLETE (with the carry-forward list). | Governance record | Phase 2 directive (FD-018 durable records) |
| **G-3 Golden Master re-baseline** | Verification-only `gm-capture` at/after `aa6d9e91` (Q-4 precedent), with its own known-defects and expected-Phase-2 delta documents, so Phase 2 Gate G starts at 0 differences. Alternative: an explicit ruling to continue the declared-difference discipline with the four E-6 differences. | Verification-only action needing authorization | Phase 2 Gate G effectiveness |
| **G-4 Phase 2b's own entry conditions** | MP-D9 ruled (or the interim Admin/Manager default explicitly extended to Phase 2b); maker-checker operation-matrix ADR (B-2) adopted. These are standing open items from the Master Plan and BACKLOG, not Phase 1 debts. | Founder decision + ADR | Phase 2b start |

Not gates, but should be scheduled independently of Phase 2: the audit-retention implementation (B-6, exposure ~2026-11-07); FD-015 implementation; release of the Phase 1 code to the live instance (MP-D3 / PD controls) - until released, the protections Phase 1 adds are not in effect on the operating system.

## Carry-forward register handed to Phase 2

CF-1..CF-9 as listed in `DEFERRED_ITEMS.md` section 4. CF-1..CF-5 are consumed by G-1; CF-7 by G-2; CF-8 by G-3; CF-6 is Phase 6; CF-9 is a release decision.

## What Phase 2 may rely on from Phase 1

- Every financial writer in `app/` sets `folio_id` through `resolve_billing_folio_id` or `inherit_billing_folio_id`; new rows cannot be unattributed.
- `audited_financial_write` / `_write_audit_strict` are the established coupling pattern for financial mutations; maker-checker approval paths that create financial rows should use them.
- `attribution_control` is the reconciliation view; the D11 bucket is reported separately and will stay non-zero on production by design.
- Recovery: `tools/restore_db.py` + rehearsal exists for `.db` artifacts; PD-006 "verified state" (B-5) is still undefined and must be settled before any production mutation Phase 2 might need (none is expected for maker-checker unless it adds schema - which would require PD-004 and B-4).

## Explicitly not decided here

No Phase 2 implementation is authorized. No change to the eight D11 rows. No schema, FK, NOT NULL, business-date, authorization, scheduler or retention change. No Golden Master recapture. No governance record edited.
